Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE v survey in 16 European countries

Kotseva K. De Backer G. De Bacquer D. Ryden L. Hoes A. Grobbee D. Maggioni A. Marques-Vidal P. Jennings C. Abreu A. Aguiar C. Badariene J. Bruthans J. Cifkova R. Davletov K. Dilic M. Dolzhenko M. Gaita D. Gotcheva N. Hasan-Ali H. Jankowski P. Lionis C. Mancas S. Milicic D. Mirrakhimov E. Oganov R. Pogosova N. Reiner Z. Vulic D. Wood D.
2021 Oxford University Press

European Journal of Preventive Cardiology
2021 #28 Issue 4 370 - 379 pp.

Background European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out by the European Society of Cardiology EURObservational Research Programme in 2016-2018. The main objective was to determine whether the 2016 Joint European Societies guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been implemented in clinical practice. Methods The method used was a cross-stional survey in 78 centres from 16 European countries. Patients without a history of atherosclerotic cardiovascular disease either started on blood pressure and/or lipid and/or glucose lowering treatments were identified and interviewed ≥ 6 months after the start of medication. Results A total of 3562 medical records were reviewed and 2759 patients (57.6% women; mean age 59.0 ± 11.6 years) interviewed (interview rate 70.0%). The risk factor control was poor with 18.1% of patients being smokers, 43.5% obese (body mass index ≥30 kg/m2) and 63.8% centrally obese (waist circumference ≥88 cm for women, ≥102 cm for men). Of patients on blood pressure lowering medication 47.0% reached the target of <140/90 mm Hg (<140/85 mm Hg in people with diabetes). Among treated dyslipidaemic patients only 46.9% attained low density lipoprotein-cholesterol target of <2.6 mmol/l. Among people treated for type 2 diabetes mellitus, 65.2% achieved the HbA1c target of <7.0%. Conclusion The primary care arm of the EUROASPIRE V survey revealed that large proportions of people at high cardiovascular disease risk have unhealthy lifestyles and inadequate control of blood pressure, lipids and diabetes. Thus, the potential to reduce the risk of future cardiovascular disease throughout Europe by improved preventive cardiology programmes is substantial.

Cardiovascular risk factors , EUROASPIRE , Guideline implementation , Primary prevention

Text of the article Перейти на текст статьи

St Marys Hospital, Imperial College Healthcare Nhs Trust, London, United Kingdom
National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Ireland
Department of Public Health and Primary Care, Ghent University, Belgium
Department of Medicine Solna, Karolinska Institutet, Sweden
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands
Maria Cecilia Hospital, GVMCare and Research Cotignola, Italy
EURObservational Research Programme, European Society of Cardiology, France
Department of Medicine, Lausanne University Hospital, Switzerland
Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Portugal
Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Portugal
Clinic of Cardiac and Vascular Diseases, Vilnius University, Lithuania
Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania
Center for Cardiovascular Prevention, Charles University in Prague, Czech Republic
Health Research Institute, Al-Farabi Kazakh National University, Kazakhstan
Medical Faculty, University of Sarajevo, Bosnia and Herzegovina
Supyk National Medical Academy of Postgraduate Education, Ukraine
Clinica de Recuperare Cardiovasculara, Universitatea de Medicina Si Farmacie Victor Babes, Romania
Department of Cardiology, National Heart Hospital, Bulgaria
Cardiovascular Medicine Department, Assiut University, Egypt
Department of Cardiology, Interventional Electro-cardiology and Hypertension, Jagiellonian University Medical College, Poland
Clinic of Social and Family Medicine, University of Crete, Greece
School of Medicine, University of Zagreb, Croatia
Kyrgyz State Medical Academy, Kyrgyzstan
National Center of Cardiology and Internal Medicine Named after Academician Mirrakhimov Mm, Kyrgyzstan
National Research Center for Preventive Medicine, Russian Federation
National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation, Russian Federation
University Hospital Centre Zagreb, University of Zagreb, Croatia
Faculty of Medicine, University of Banja Luka, Bosnia and Herzegovina

St Marys Hospital
National Institute for Prevention and Cardiovascular Health
Department of Public Health and Primary Care
Department of Medicine Solna
Julius Center for Health Sciences and Primary Care
Maria Cecilia Hospital
EURObservational Research Programme
Department of Medicine
Hospital Santa Marta
Hospital Santa Cruz
Clinic of Cardiac and Vascular Diseases
Centre of Cardiology and Angiology
Center for Cardiovascular Prevention
Health Research Institute
Medical Faculty
Supyk National Medical Academy of Postgraduate Education
Clinica de Recuperare Cardiovasculara
Department of Cardiology
Cardiovascular Medicine Department
Department of Cardiology
Clinic of Social and Family Medicine
School of Medicine
Kyrgyz State Medical Academy
National Center of Cardiology and Internal Medicine Named after Academician Mirrakhimov Mm
National Research Center for Preventive Medicine
National Medical Research Center of Cardiology
University Hospital Centre Zagreb
Faculty of Medicine

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026